EP1322659A4 - 21 humane sezernierte proteine - Google Patents

21 humane sezernierte proteine

Info

Publication number
EP1322659A4
EP1322659A4 EP01985257A EP01985257A EP1322659A4 EP 1322659 A4 EP1322659 A4 EP 1322659A4 EP 01985257 A EP01985257 A EP 01985257A EP 01985257 A EP01985257 A EP 01985257A EP 1322659 A4 EP1322659 A4 EP 1322659A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01985257A
Other languages
English (en)
French (fr)
Other versions
EP1322659A1 (de
Inventor
Craig A Rosen
George A Komatsoulis
Kevin P Baker
Charles E Birse
Daniel R Soppet
Henrik S Olsen
Paul A Moore
Ping Wei
Reinhard Ebner
D Roxanne Duan
Yanggu Shi
Gil H Choi
Michele Fiscella
Jian Ni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1322659A1 publication Critical patent/EP1322659A1/de
Publication of EP1322659A4 publication Critical patent/EP1322659A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP01985257A 2000-09-20 2001-01-17 21 humane sezernierte proteine Withdrawn EP1322659A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23421000P 2000-09-20 2000-09-20
US234210P 2000-09-20
PCT/US2001/001565 WO2002024719A1 (en) 2000-09-20 2001-01-17 21 human secreted proteins

Publications (2)

Publication Number Publication Date
EP1322659A1 EP1322659A1 (de) 2003-07-02
EP1322659A4 true EP1322659A4 (de) 2005-01-26

Family

ID=22880406

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01985257A Withdrawn EP1322659A4 (de) 2000-09-20 2001-01-17 21 humane sezernierte proteine

Country Status (4)

Country Link
EP (1) EP1322659A4 (de)
AU (1) AU2001229563A1 (de)
CA (1) CA2420192A1 (de)
WO (1) WO2002024719A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1573024A4 (de) 2001-04-10 2007-08-29 Agensys Inc Nukleinsäuren und diesen entprechende, für die behandlung und den nachweis verschiedener krebserkrankungen geeignete proteine
GEP20115226B (en) 2005-04-26 2011-06-10 Pfizer P-cadherin antibodies
ES2546069T3 (es) 2005-09-07 2015-09-18 Amgen Fremont Inc. Anticuerpos monoclonales humanos para quinasa-1 de tipo receptor de activina (ALK-1)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060020A1 (en) * 1998-05-18 1999-11-25 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1999066041A1 (en) * 1998-06-16 1999-12-23 Human Genome Sciences, Inc. 94 human secreted proteins
WO2001055440A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001077137A1 (en) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Albumin fusion proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1490386E (pt) * 1998-03-10 2008-11-24 Genentech Inc Novos polipéptidos e ácidos nucleicos que os codificam

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060020A1 (en) * 1998-05-18 1999-11-25 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1999066041A1 (en) * 1998-06-16 1999-12-23 Human Genome Sciences, Inc. 94 human secreted proteins
WO2001055440A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001077137A1 (en) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Albumin fusion proteins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 10 December 1999 (1999-12-10), XP002307249, retrieved from EBI Database accession no. AP000822 *
DATABASE EMBL 27 August 2002 (2002-08-27), XP002307248, retrieved from EBI Database accession no. ABG64956 *
DATABASE EMBL 7 November 2001 (2001-11-07), XP002307247, retrieved from EBI Database accession no. AAS28465 *
ERMOLAEVA O ET AL: "DATA MANAGEMENT AND ANALYSIS FOR GENE EXPRESSION ARRAYS", NATURE GENETICS, NEW YORK, NY, US, vol. 20, 20 September 1998 (1998-09-20), pages 19 - 23, XP002916034, ISSN: 1061-4036 *
See also references of WO0224719A1 *

Also Published As

Publication number Publication date
AU2001229563A1 (en) 2002-04-02
CA2420192A1 (en) 2002-03-28
WO2002024719A1 (en) 2002-03-28
EP1322659A1 (de) 2003-07-02

Similar Documents

Publication Publication Date Title
EP1181390A4 (de) 27 menschliche, sekretierte proteine
EP1251863A4 (de) 22 sezernierte humane proteine
EP1175438A4 (de) 62 humane sekretierte proteine
EP1165827A4 (de) 45 humane sekretierte proteine
EP1175439A4 (de) 49 humane sekretierte proteine
EP1159284A4 (de) 33 human sekrteierte proteine
EP1254242A4 (de) 17 humane sekretierte proteine
EP1368468A4 (de) Menschliche sezernierte proteine
EP1173477A4 (de) 49 humane sekretierte Proteine
EP1144614A4 (de) Menschliche, ausgeschiedene proteine
EP1171460A4 (de) 48 menschliche sekretierte proteine
EP1165602A4 (de) 49 menschliche, sekretierte proteine
EP1169332A4 (de) 49 human sekrtierte proteine
EP1370651A4 (de) 70 humane sekretierte proteines
EP1165828A4 (de) 50 menschliche sekretierte proteine
EP1317471A4 (de) 21 menschliche sekretierte proteine
EP1185285A4 (de) 49 humane sekretierte proteine
EP1322657A4 (de) 22 humane sezernierte proteine
EP1317472A4 (de) 17 menschliche sekretierte proteine
EP1181303A4 (de) 50 human-ausgeschiedene proteine
EP1159287A4 (de) 50 menschliche sekretierte proteine
EP1165123A4 (de) 48 menschliche sekretierte proteine
EP1171626A4 (de) 50 humane sekretierte proteine
EP1165591A4 (de) 47 menschliche sekretierte proteine
EP1322659A4 (de) 21 humane sezernierte proteine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030325

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041210

17Q First examination report despatched

Effective date: 20050704

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051105